Bayesian Capital Management’s ING ING Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,400
Closed -$293K 662
2025
Q2
$293K Buy
+13,400
New +$271K 0.05% 397
2025
Q1
Sell
-23,488
Closed -$368K 776
2024
Q4
$368K Buy
+23,488
New +$382K 0.05% 444
2023
Q3
Sell
-11,000
Closed -$148K 837
2023
Q2
$148K Buy
+11,000
New +$141K 0.02% 667
2023
Q1
Sell
-21,500
Closed -$262K 937
2022
Q4
$262K Buy
+21,500
New +$234K 0.04% 527
2022
Q2
Sell
-35,200
Closed -$367K 921
2022
Q1
$367K Buy
+35,200
New +$459K 0.05% 465
2021
Q1
Sell
-57,100
Closed -$539K 611
2020
Q4
$539K Buy
57,100
+38,400
+205% +$329K 0.14% 204
2020
Q3
$132K Buy
+18,700
New +$143K 0.03% 465
2019
Q3
Sell
-11,600
Closed -$134K 594
2019
Q2
$134K Sell
11,600
-79,800
-87% -$951K 0.03% 452
2019
Q1
$1.11M Buy
91,400
+42,500
+87% +$514K 0.21% 145
2018
Q4
$521K Buy
+48,900
New +$588K 0.11% 275
2017
Q1
Sell
-17,500
Closed -$247K 540
2016
Q4
$247K Sell
17,500
-6,681
-28% -$90K 0.06% 470
2016
Q3
$298K Buy
24,181
+11,186
+86% +$130K 0.2% 196
2016
Q2
$134K Sell
12,995
-15,805
-55% -$187K 0.08% 350
2016
Q1
$344K Buy
+28,800
New +$346K 0.32% 112

Other funds holding ING

Bayesian Capital Management's ING Position: Q3 2025 in Review

Bayesian Capital Management sold out of ING (ING) in Q3 2025, closing a stake of 13,400 shares — an estimated $293K sold.

Bayesian Capital Management first reported a position in ING in Q1 2016 and held it in 14 quarters. The position peaked at $1.11M in Q1 2019. 462 funds tracked by Wall St. Rank hold ING as of Q3 2025.

  • Bayesian Capital Management reported no remaining ING position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 13,400 ING shares in Q3 2025, an estimated $293K.
  • Bayesian Capital Management first reported a position in ING in Q1 2016 and held it in 14 quarters.
  • Bayesian Capital Management's ING position peaked at $1.11M in Q1 2019.
  • 462 funds tracked by Wall St. Rank held ING as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.